Stanford University
Showing 441-460 of 796 Results
-
Heng Zhao
Member, Wu Tsai Neurosciences Institute
Current Research and Scholarly InterestsMy lab is focused on developing novel therapeutic methods against stroke using rodent models. We study protective effect of postconditioning, preconditioning and mild hypothermia. The rationale for studying three means of neuroprotection is that we may discover mechanisms that these treatments have in common. Conversely, if they have differing mechanisms, we will be able to offer more than one treatment for stroke and increase a patientÂ’s chance for recovery.
-
Kewei Zhao
Postdoctoral Scholar, Photon Science, SLAC
Current Research and Scholarly InterestsInvestigation of catalytic mechanism of metalloenzyme with spectroscopy methods.
-
Lilac Zihui Zhao
Affiliate, Medicine - Primary Care and Population Health
BioI am a Clinical Data Scientist at a global healthcare company based in UK and am also affiliated with Stanford School of Medicine. I specialize in AI engineering, with a focus on unstructured clinical notes and brain imaging data. Previously, I was a data scientist/social science research scholar in Stanford's Division of Primary Care and Population Health and a Visiting Faculty (Lecturer) at Dartmouth College, where I taught undergraduate statistics. I have also worked as a short-term consultant at the World Bank.
Relevant Medical Papers:
Cognition Trajectories: A Quasi-Experimental Study. (Revision Requested at Cell, first-author) -
Liming Zhao
Affiliate, Stem Cell Bio Regenerative Med Institute
BioDr. Zhao is currently a postdoctoral scholar at Stanford University. He received his MD degree from Tongji Medical College, Huazhong University of Science and Technology in 2018.
-
Man Zhao
Postdoctoral Scholar, Radiation Biology
BioMy research primarily focuses on the molecular mechanisms, signaling pathways, and therapeutic targets underlying cancer metabolism, particularly the m6A demethylase FTO. I am also actively exploring the interplay between tumor metabolism and tumor immunity, with the goal of identifying novel metabolic vulnerabilities for cancer treatment.
